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Polychiorinated Dibenzodioxins and
Polychiorinated Dibenzofurans*:
by J. E. Huff,t J. A. Moore,t R. Saracci,* and L. Tomatis*
During January 10-11, 1978 in Lyon, France, a joint National Institute of Environmental
Health Sciences/International Agency for Research on Cancer ad hocWorking Group consid-
ered and discussed the feasibility ofcoordinatingepidemiological studies on the long-term haz-
ards associated with the chlorinated dibenzo-p-dioxins and chlorinated dibenzofurans (PCDDs
and PCDFs). Nineteen invited scientists from eight countries presented introductory working
papers summarizing the most up-to-date andrelevant information available fromtheir individ-
ual programs. This report represents the collective views and scientific opinions ofthe Working
Group. The greater part ofthis document comprises epidemiological studies related to episodes
ofhuman exposure. The review begins with abriefsection concerning possible routes of human
exposure, an overview of the pertinent chemical characteristics, and the salient toxicological
properties of the structurally siimilar PCDDs/PCDFs. The Working Group report ends with
recommendations for future activities.
Introduction
Human exposure in the workplace can occur
when chlorinated dibenzo-p-dioxins (PCDDs) are
formed during the production of certain com-
pounds such as the herbicide 2,4,5-tri-
chlorophenoxyacetic acid (2,4,5-T), the fungicide
pentachlorophenol, and the germicide hexachloro-
phene (1). The dioxins, impurities/contaminants
associated with these end-products, result most
often from treatment of chlorinated benzenes at
elevated temperature and pressure under alkaline
conditions. Via the widespread use of these com-
mercial products (1, 2) the general population
may also become exposed.
In recent years, out-of-control chemical reac-
tions during the production of 2,4,5-tri-
chlorophenol have proceeded to the explosive
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November 1980 221stage thereby exposing persons to toxic levels of
PCDDs. From certain of these accidents, more-
over, not only did those occupationally involved
receive dangerous exposure but also those in-
habiting the surrounding areas received uncom-
mon risk.
The structurally-related chlorinated dibenzofu-
rans (PCDFs) are contaminants found in some
polychlorinated biphenyl compounds: Aroclor, Clo-
phen, Phenoclor (3).
These impurities are more toxic and represent
a greater environmental hazard than the com-
pounds they contaminate (1, 3-9). For instance,
2,3,7,8-tetra-CDD has been recently found in beef
fat from cattle grazed on 2,4,5-T-treated range-
land and in breast milk from women living in
areas where 2,4,5-T is used on rangeland or in for-
est areas (10). Various investigators (11-14)
have also discovered PCDDs and PCDFs in fly ash
and flue gas from municipal incinerators, and in
dust from fungicide-treated wood (15).
Chemical Aspects
The PCDDs and PCDFs are two series of tri-
cyclic aromatic compounds which exhibit similar
chemical and physical properties (1, 3, 4). The
basic two-dimensional structures (I, II) have
eight possible points of chemical addition. From
the monochloro to the octachloro derivatives, a va-
riety of positional isomers are possible: 75 PCDDs
and 135 PCDFs (Table 1).
The extreme toxic potency of some of these
compounds, as well as the large number of poten-
tial isomers, warrant analytical methods exhib-
iting high sensitivity and specificity to monitor
the environment. A desirable detection limit of
one part per trillion (ppt, 1 picogram/gram
sample) is being reached with current methodol-
ogy. Essential requirements included efficient
clean-up, good separation and selectivity, ultra-
sensitive quantification, and validation (16, 17).
Toxicological Aspects
Animals
The prototype and most extensively studied iso-
mer of the PCDDs and PCDFs is the 2,3,7,8-tet-
rachlorodibenzo-p-dioxin (2,3,7,8-tetra-CDD),
perhaps the most potent man-made toxin pres-
ently known. The comparative oral lethal dose val-
ues for various PCDDs in mice and guinea pigs
(Table 2) show clearly that the 2,3,7,8-tetra-CDD
and the 1,2,3,7,8-penta-CDD isomers are the most
toxic (18).
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Toxic effects induced by PCDDs and PCDFs
vary quantitatively and qualitatively among dif-
ferent species; however, within a single species
the untoward consequences are markedly similar
for all PCDDs and PCDFs that have been studied.
For example, the toxic effects induced by 2,3,7,8-
tetra-CDD which are most often observed in mice,
guinea-pigs, and monkeys, are illustrated in Table
3 (20). In a brief report, daily oral intake (12-61
days) of <1 ,ug/kg body weight 2,3,7,8-tetra-CDD
was stated as being lethal to young male rhesus
monkeys (21), whereas McConnell et al. (22) re-
ported an LD. in female rhesus monkeys as <70
,tg/kg body weight.
A preliminary report on 2,3,7,8-tetra-CDF con-
cerning the toxicity of PCDFs (23), and a report
on PCDFs (24) have been published.
The toxic syndrome produced by PCDDs and
PCDFs may be divided into seven categories:
Chloracne. 2,3,7,8-Tetra-CDD and the tri-
PCDF and tetra-PCDF were found to be active
skin irritants and to induce acneform lesions in
the skin of rabbit ears (25).
Classical chloracne is a hallmark of PCDD ex-
posure in humans and an analogous hyper-
keratosis and the modulation of sebaceous struc-
tures to keratin cysts have been observed in
monkeys, rabbits, and hairless mice.
Chloracne or acneform dermatitis is a common
occupational dermatitis characterized by com-
edones, keratin cysts, pustules, papules, and ab-
scesses. In 1957, Kimmig and Schulz (26) found
that 2,3,7,8-tetra-CDD was the agent responsible
for causing occupational chloracne in employees
of chlorophenol-producing factories. Further, in
1971 PCDDs were implicated as causing chloracne
in male workers in a plant producing 2,4-D and
2,4,5-T (27, 28). Chloracne may appear weeks or
months after the initial exposure to PCDDs and
PCDFs.
Hepatoxicity. The degree of hepatic in-
volvement appears to be dose-dependent, and the
severity of the changes produced varies between
species (29). Hepatic necrosis produced by 2,3,7,8-
tetra-CDD is probably a contributing cause of
death in rats and rabbits, while hepatic necrosis
and liver insufficiency are less extensive in mice
and are minimal in comparison in guinea pigs and
monkeys (22, 30-37). Hepatic porphyrin accumu-
lation has been observed in mice, rats, and chick-
ens.
Hypoplasia of the Lymphoid Tis-
sues. Particularly involved are the cortical cells
of the thymus and this hypoplasia has been ob-
served in mice, rats, guinea-pigs, and monkeys.
The most significant findings in both mice and
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guinea-pigs treated with sublethal doses of
2,3,7,8-tetra-CDD were in the lymphoid system,
resulting in suppression of cell-mediated immu-
nity, particularly in young animals (36, 38). Low
levels of 2,3,7,8-tetra-CDD that did not produce
overt clinical or pathological changes still reduced
host defences: 1 ,ug/kg bw given orally once
weekly for 4 weeks to mice before infection with
Salmonella increased mortality and decreased the
time from infection to death (39). The increased
mortality may be caused by the endotoxin content
of these gram negative bacteria, since 2,3,7,8-
tetra-CDD markedly increases the susceptibility
of mice to endotoxin (lipopolysaccharide of Esche-
richia coli) (40). Treatment of female mice and
rats with 2,3,7,8-tetra-CDD during the latter half
of gestation and in the postnatal period resulted
in a severe depletion of lymphocytes in the thymic
cortex of the offspring (41). Cellular immunity
was impaired.
Hematological changes in mice, rats, and
guinea pigs treated with 2,3,7,8-tetra-CDD in-
clude lymphopenia and thrombocytopenia (42,
43); manifest also is an increased susceptibility to
infection concomitant with the suppression of
cell-mediated immunity. For 9 months, female
rhesus monkeys received a diet containing 500 ppt
2,3,7,8-tetra-CDD; within 6 months, the monkeys
became anemic and after 9 months pancytopenic
Table 1. Possible number ofisomers forpolychlorinated
dibenzo-p-dioxins andpolychlorinated dibenzofurans.
Chlorine PCDD PCDF
atoms isomersa isomersb
1 2 4
2 10 16
3 14 28
4 22 38
5 14 28
6 10 16
7 2 4
8 1 1
Total 75 135
a Chlorinated dibenzo-dioxins: empirical formula C12H7-0
C11802; molecular weight ranges, 218-460.
b Chlorinated dibenzofurans: empirical formula, C12H7-0
Cll80; molecular weight ranges, 202-444.
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(44). The marked thrombocytopenia was associ-
ated with widespread hemorrhage. Death oc-
curred in five of the eight monkeys between
months 7 and 12 of the experiment at total ex-
posure levels of 2,3,7,8-tetra-CDD of 2-3 ,ug/kg
body weight. At autopsy, in addition to extensive
hemorrhage, there was a distinct hypocellularity
of the bone marrow and lymph nodes. Hyper-
trophy, hyperplasia, and metaplasia of the epithe-
lium in the bronchial tree, bile ducts, pancreatic
ducts, salivary-gland ducts, and palpebral con-
junctivae were observed. Squamous metaplasia
and keratinization of the sebaceous glands and
hair follicles were present in the skin. Death was
attributed to complications from the severe pan-
cytopenia (44).
General Debilitation and Wasting. Animals
that receive a toxic or lethal dose of PCDDs or
PCDFs exhibit a chronic and progressive weight
loss with parallel mobilization of peripheral fat,
increased serum triglyceride levels, and develop-
ment of a fatty liver. Death due to PCDDs or
PCDFs intoxication is delayed, as exemplified by
an elapsed time period of 6 to 8 weeks following
administration of a lethal dose and eventual death
(18, 22, 44).
Embryotoxicity and Teratogenicity of2,3,7,8-
tetra-CDD. In repeated or single doses of
2,3,7,8-tetra-CDD to mice, as little as 1-10 ltg/kg
cause increased frequencies of cleft palate and
kidney abnormalities (45-48) (see Table 4). In
rats, embryo-lethal effects occur under experi-
mental conditions (49, 50), and kidney anomalies
(45), intestinal hemorrhages, and general edema
can be produced in the fetuses (51). Few follow-
up studies of the effects of prenatal exposure on
postnatal functions have been published. In mice,
fetal kidney abnormalities caused by 2,3,7,8-tetra-
CDD may progress into a hydronephrosis during
the postnatal period (52).
Chick Edema Disease. Hydropericardium, as-
cites, subcutaneous edema, liver necrosis, and
death were described in 1957 following the acci-
dental administration of toxic fats in the feed of
broiler chickens (ascites have been observed also
in mice) (1). The toxic material was later identi-
223Table 2. Estimated single oral LD50-30 values ofcertain polychlorinated dibenzo-p-dioxin isomers.a
Guinea pigs Mice
Chlorine isomer Ag/kg umole/kg jig/kg gmole/kg
2,8 >300,000 >1,180
2,3,7 29,444 120.41 >3,000 >10
2,3,7,8 2 0.006 283.7 0.88
1,2,3,7,8 3.1 0.009 337.5 0.94
1,2,4,7,8 1,125 3.15 >5,000 >14
1,2,3,4,7,8 72.5 0.185 825 2.11
1,2,3,6,7,8 70-lOOb 0.178-0.255 1,250 3.19
1,2,3,7,8,9 60-lOOb 0.153-0.255 >1,440 >3.67
1,2,3,4,6,7,8 >600 >1.400
1-NO2-3,7,8 >30,000 >90
1-NH2-3,7,8 >30,000 >99
1-NO2-2,3,7,8 47.5 0.129 >2,000 >5.4
1-NH2-2,3,7,8 194.2 0.576 >4,800 >14.2
a Data from McConnell et al. (18). The LD50_30 was calculated by the Spearman-Karber method (19).
b Estimated range due to variability in replicates.
fied in commercial oleic and stearic acids produced
from inedible tallow recovered from animal hides;
trichlorophenols and pentachlorophenols had been
used in the curing of the hides. The edema causa-
tive was termed toxic fat and more specifically
chick edema factor and was characterized by x-
ray crystallography as 1,2,3,7,8,9-hexa-CDD (53).
2,3,7,8-Tetra-CDD, hexa-CDD, and octa-CDD
have been also identified in several commercial
fatty'acids (54). Daily doses of 10 or 100 ,ug hexa-
CDD/kg bw, or of 1 or 10,ug 2,3,7,8-tetra-CDD/kg
bw, produced a positive response in the chick
edema bioassay; 0.5% octa-CDD in the diet had no
effect (35). Similar edematous effects were ob-
served in rats, pigs, dogs, and monkeys, but not in
Table 3. Summary ofthe toxic effects of2,3,7,8-
tetrachlorodibenzo-p-dioxin.a
Guinea Monkeys
Mice pigs (female)
Thymus involution +++ +++ +++
Spleen reduction + + +
(white pulp)
Bone marrow hypoplasia ± ++ +
Liver megalocytosis/generation +++ - -
Bile ducthyperplasia +++
Testicular degeneration ++ +++ NA
Renal pelvishyperplasia - ++ +
Urinary bladderhyperplasia - ++ -
Adrenal cortical atrophy - ++ -
(zona glomerulosa)
Hemorrhage
Intestinal + + -
Adrenal - ++ -
Ascites ++ - +
Cutaneous lesions - - +++
I Data from Moore (20).
guinea pigs (55). Decreased serum albumin may
be associated with the edema; edema has been
also shown to occur in chicks dosed orally with
2,3,7,8-tetra-CDF (56).
Other Effects. In one or more species of labo-
ratory animals, bone marrow hypoplasia, testicu-
lar degeneration, renal pelvis and urinary bladder
hyperplasia, and hemorrhage in the intestines
and adrenals have been observed.
Enzyme Induction. 2,3,7,8-Tetra-CDD and
other halogenated dibenzo-p-dioxins and diben-
zofurans stimulate a number of enzyme activities,
most notably in the liver (1). 2,3,7,8-Tetra-CDD is
a potent inducer of hepatic and renal microsomal
drug metabolizing enzymes (57-69). Intoxication
with 2,3,7,8-tetra-CDD results in a marked in-
crease in the cellular smooth endoplasmic reticu-
lum content of hepatic and renal cells (60,69).
2,3,7,8-Tetra-CDD can simultaneously activate
and suppress certain microsome-associated for-
eign-compound and steroid-hormone-metabo-
lizingenzyme systems (63) as well as increase the
activity of both renal and hepatic glutathione-S
transferase (70).
2,3,7,8-Tetra-CDD is the most active of the
PCDDs in inducing hepatic O-aminolevulinic acid
(ALA) synthetase and aryl hydrocarbon hydroxy-
lase (AHH) in chick embryo liver preparations
(71, 72).
The PCDDs that induce ALA synthetase in
chick embryo have two common properties: (1)
halogen atoms occupy at least three of the four
ring positions (2,3,7,8), and (2) at least one free,
nonhalogenated carbon atom is unoccupied (71).
The available toxicological data (35) indicate that
those PCDDs that are lethal at low doses, terato-
genic, or produce acne also induce ALA synthe-
Environmental Health Perspectives 224Table 4. Evaluation ofreported embryotoxic and teratogenicefrects induced by2,3,7,8-tetrachlorodibenzo-p-dioxins in rats
and micea
Dose, ug/kg
Embryotoxic/ Lowest Period of
Species Strain teratogenic effect Testedb ED50C dosing, days Route Reference
Rat Intestinal hemorrhage 0.125 0.5? Oral (50)
CD Kidney abnormality 0.5 >1 6-15 S.C. (45)
Mouse CD-1 Cleftpalate 1?
3 >3 6-15 S.C. (45)
Kidney abnormality 1 1-3 6-15 S.C. (45)
DBA/2J Cleft palate 3 >3 6-15 S.C. (45)
Kidney abnormality 3 >3 6-15 S.C. (45)
C57BL/6J Cleft palate 3 >3 6-15 S.C. (45)
Kidney abnormality 3 <3 6-15 S.C. (45)
NMRI Cleft palate 3 6.5 6-15 Oral (46)
9 <9 9-13 Oral (46)
15 40 13 Oral (47)
5 15 11 Oral (47)
a Data from Neubert et al. (47).
b The lowest dose with which an embryotoxic or teratogenic effect detectable at birth has been produced is indicated. Since
sometimes only one dose level was tested, this does not necessarily represent the lowest dose from which an effect could result.
c ED50-dose required to produce an embryotoxic effect in 50% of animals.
tase; those PCDDs that are not toxic generally do
not induce ALA synthetase. The structure-activ-
ity relation of PCDDs to induce AHH in chick em-
bryos was identical to that in inducing ALA syn-
thetase (71).
Mixed-function oxidase enzyme systems of
mouse strains "non-responsive" to other aromatic
hydrocarbons were induced by single doses of
2,3,7,8-tetra-CDD, as evidenced by increases in
hepatic monooxygenase activities and in concen-
trations of cytochrome P-448 (73-76). Genetic
resistance to induction of AHH by 3-methyl-
cholanthrene in DBA/2J mice was overcome by
treatment with 2,3,7,8-tetra-CDD. This result con-
flicts with the hypothesis that induction of AHH
activity is a consequence of the formation of cyto-
chrome P-448 (77). A component that has a high
binding affinity for 2,3,7,8-tetra-CDD was found
in mouse liver cytosol (78).
2,3,7,8-Tetra-CDD induces AHH even in 'poorly
responsive' strains of mice (79), not only in liver
but also in lung, kidney, and colon. The DBA/2N
strain, which responds only weakly to the sarco-
matogenic action of 3-methylcholanthrene, be-
comes highly susceptible after treatment with
2,3,7,8-tetra-CDD (74, 80).
2,3,7,8-Tetra-CDD is approximately 30,000
times more potent than 3-methylcholanthrene in
inducing AHH activity in rat liver (81).
McConnell et al. (18) reported that the com-
parative toxicity of 13 PCDDs in mice and
guinea-pigs (see Table 2) supports the idea that
the relative potency (or rank order) of a congener
to produce one toxic response is a good indicator
of its relative potency (or rank order) to produce
other toxic manifestations.
Hepatic Cytosol Binding Protein. A macro-
molecular binding species has been characterized
in the hepatic cytosol fraction of mouse and rat
liver which has the in vitro binding properties
predicted for the receptor for the induction of
AHH activity based on the in vivo biology (78):
namely, (1) 3H-2,3,7,8-tetra-CDD binds to this
cytosol protein reversibly with a high affinity (Kd
= 0.27 nM) comparable to the ED., for hepatic
AHH induction (ED50 in mice = 1 nmole/kg); (2)
the binding affinity of halogenated dibenzo-p-di-
oxins and dibenzofurans for this protein in vitro
corresponds to their potency to induce hepatic
AHH activity in the chicken embryo; and (3)
other compounds, such as the polycyclic aromatic
hydrocarbons, which induce AHH activity and
cytochrome P1-450 also compete for this cytosolic
binding protein, but compounds which induce
other types of microsomal monooxygenase activi-
ties (e.g., phenobarbital) and steroids fail to bind.
Thus, this cytosolic binding protein may be the re-
ceptor for the induction of AHH activity.
Structure-Activity Relations. The pathologic
effects produced by the toxic PCDD and PCDF
isomers are similar to those of 2,3,7,8-tetra-CDD
for a given species, differing only in the intensity
of the toxic effect produced by a given isomer.
The toxic PCDDs have chlorine atoms in at least
three of the four lateral ring positions (2,3,7, and
8) with at least one unsubstituted ring position
(the octa-CDD is comparatively inactive). To the
extent that the toxicity has been determined, a
November 1980 225similar structure-toxicity relation has been ob-
served for the PCDFs.
The structure-activity relation established for
PCDDs and PCDFs for the induction of hepatic
aryl hydrocarbon hydroxylase (AHH) activity
and for binding. to the hepatic cytosol binding
species has been extended to other classes of
chlorinated aromatic compounds. 3,4,3'4'-Tetra-
chloroazoxybenzene (TCAOB) and 3,4,3',4'-tet-
rachloroazobenzene (TCAB) are potent acnegens
formed as trace contaminants in the synthesis of
3,4-dichloroaniline or herbicides based on this
compound (82). At high doses in aniimals, TCAB
is reported to produce thymic involution and liver
damage similar to 2,3,7,8-tetra-CDD (83). Both
TCAOB and TCAB are potent inducers of hepatic
AHH activity and bind to the hepatic cytosol
binding protein with a high affinity. Congeners
such as 3,5,3'5'-tetrachloroazoxybenzene and
3,5,3',5'-tetrachloroazobenzene fail to induce AHH
activity, fail to bind to the hepatic cytosol species,
and fail to produce chloracne.
Of 16 halogenated biphenyl compounds tested,
only 3,4,3'4'-tetrachloro-, 3,4,5,3'4'5'-hexachloro-
and 3,4,5,3'4'5'-hexabromobiphenyls induced
hepatic AHH activity and bound to the hepatic
cytosol binding species (84). The 3,4,3'4'-tetrach-
lorobiphenyl has been reported to produce chlor-
acne. McKinney et al. (56) found that of five
hexachlorobiphenyls tested in chickens,
3,4,5,3'4'5'-hexachlorobiphenyl was by far the
most toxic, and the only one that induced signifi-
cant chick edema and involution of the thymus.
Pharmacokinetics. In the rat, following acute
or chronic administration, 2,3,7,8-tetra-CDD is ac-
cumulated primarily in the liver and to a lesser
extent in the fat, and is largely eliminated unme-
tabolized in the feceswith awhole bodyhalf-life of
about 3 weeks. Some pharmacokinetic experi-
ments suggest the formation of a polar metabo-
lite appearing in the urine, but direct attempts to
demonstrate metabolism with hepatic microsomes
in vitro have been negative (1).
Mutagenicity. Only four dioxin isomers have
been evaluated for mutagenicity: the 2,7-di-,
2,3,7,8-tetra, and octa-CDDs as well as the un-
substituted dibenzo-p-dioxin (85).
2,3,7,8-Tetra-CDD increased the reversion fre-
quency to streptomycin independence in Esche-
richia coli Sd-4. In Salmonella typhimurium,
frameshift mutations in strain TA1532, but not
base substitutions in strain TA1530, were induced
by toxic concentrations of 2,3,7,8-tetra-CDD (86).
In plate assays, the response was positive with S.
typhimurium TA1532, doubtful with TA1531 and
TA1534, and negative with G46 and TA1530 (87).
McCann (88) tested 2,3,7,8-tetra-CDD in S. typh-
imurium, both with and without metabolic acti-
vation, using a spot-test and the standard' plate
test with strains TA1532, TA1535, TA1537, and
TA1538; all these tests were negative.
Octa-CDD was nonmutagenic in S. typhimur-
ium strains G46, TA1530, and TA1531, and doubt-
ful results were obtained with strains TA1532 and
TA1534 (87). Metabolic activation systems were
not included in any of these microbiological as-
says.
Inhibition of mitosis and chromosomal abnor-
malities (dicentric bridges and chromatin fusion
with formation of multinuclei or a single large
nucleus) were observed in endosperm cells of the
African blood lily (Haemanthus Katherinae
Baker) treated with 2,3,7,8-tetra-CDD in the
presence or absence of 2,4,5-T (89).
No chromosomal aberrations were observed in
bone marrow cells of male rats treated with 2,7-
di-CDD, 2,3,7,8-tetra-CDD, or dibenzo-p-dioxin by
oral intubation, with 2,3,7,8-tetra-CDD by intra-
peritoneal injection or orally (90). However, when
Osborne Mendel rats of both sexes were treated
twice weekly for 13 weeks with 2,3,7,8-tetra-CDD,
a significant but weak increase in the number of
chromosome aberrations in bone marrow cells was
reported (91).
2,3,7,8-Tetra-CDD did not induce dominant le-
thal mutations in Wistar rats after oral adminis-
tration to males for 7 days (51).
Carcinogenicity. Two reports indicate that
chronic administration of low levels of 2,3,7,8-
tetra-CDD to rats is associated with an increased
incidence of neoplasia (1, 92, 93).
Groups of 10 male Sprague-Dawley rats were
fed a diet containing 2,3,7,8-tetra-CDD for 78
weeks in the following amounts (figures in paren-
theses are approximate weekly doses): 0, 1 ppt
(0.0003 ,ug/kg body weight) 5 ppt (0.001 ,tg/kg),
50 ppt (0.01 Ag/kg), 500 ppt (0.1 ,g/kg), 1 ppb
(0.4,g/kg), 5 ppb (2.0,g/kg), 50 ppb (24 ,ug/kg),
500 ppb (240 Ag/kg), and 1000 ppb (500 Ag/kg).
The three highest dose levels (50, 500, and 1000
ppb) were toxic and killed all animals by the
fourth week. Of the six remaining test groups,
the overall incidence of neoplasms was 23/60
(38%); none occurred in the 1 ppt group. In the 5
ppt group, 5/10 animals had 6 neoplasms [ear-
duct carcinoma, lymnphocytic leukemia, adeno-
carcinoma, malignant histocytoma (with metas-
tases), angiosarcoma, Leydig-cell adenoma]; the
following groups also showed neoplasms: 50 ppt,
three observed in 3/10; 500 ppt, four 4/10; 1 ppb,
five observed in 4/10; 5 ppb, ten observed in 7/10.
Neoplasms were not observed in the controls (92).
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and 50 females) received for two years diets con-
taining 0, 22, 210, and 22,000 ppt, equivalent to
0.0, 0.001, 0.01, and 0.1 ,ug 2,3,7,8-tetra-CDD/kg/
day. Continuous ingestion of 0.001 ,g/kg/day did
not cause any chemically related changes in tumor
incidence or toxicity; feeding with 0.01 ,ug/kg/day
induced an increased incidence (p < 0.05) of he-
patocellular hyperplastic nodules (female: 18/50
versus 8/86 controls), of focal alveolar hyper-
plasia in the lungs, and of urinary excretion of
porphyrins (female). Dietary intake of 0.1Ag/kg/
day caused an increased incidence (p < 0.05) of
hepatocellular carcinomas (female: 11/49 versus
1/86) and squamous-cell carcinomas of the lung
(female: 7/49 versus 0/86), of the hard palate/
nasal turbinates (male: 4/50 versus 0/85; female:
4/49 versus 0/86), and of the tongue (male: 3/50
versus 0/85). Further increased were adenoma of
the adrenal cortex (male) and hepatocellular hy-
perplastic nodules (female). At this dose, certain
age-related lesions were reduced (males: acinar
adenoma of the pancreas; females: granulosal cell
neoplasm of the ovary, benign and malignant tu-
mors of the mammary gland, pituitary adenoma,
and benign tumors of the uterus). Also, chronic
administration of 2,3,7,8-tetra-CDD caused mul-
tiple toxicologic effects, including increased mor-
tality, decreased body weight gain, slight depres-
sion of certain hematologic parameters, increased
urinary excretion of porphyrins and 6-amino-
levulinic acid, increased serum levels of alkaline
phosphatase, glutamyl transferase and serum glu-
tamic pyruvic transaminase, and morphologic
changes primarily of the hepatic, lymphoid, res-
piratory, and vascular tissues of the body (93).
These two reports show that chronic adminis-
tration of 2,3,7,8-tetra CDD causes an increased
incidence of neoplasms, but not whether 2,3,7,8-
tetra-CDD acts as an initiator or promoter. This
consideration is particularly important because
unequivocal evidence is lacking that 2,3,7,8-tetra-
CDD is a mutagen or is metabolized, and no evi-
dence is available that 2,3,7,8-tetra-CDD and/or
metabolite(s) bind covalently to macromolecules.
As summarized in Table 5, at least 24 long-term
carcin6genicity studies on mice and rats are in
progress (94).
Humans
Toxic Effects in Humans. Toxicity due to
2,3,7,8-tetra-CDD has been reported after occupa-
tional exposure during the industrial synthesis of
2,4,5-trichlorophenol (TCP) and 2,4,5-T, after ex-
posure in factories and in the surrounding envi-
ronment due to accidents occurring during the
synthesis of TCP, and after exposure to herbi-
cides and other materials containing 2,3,7,8-tetra-
CDD. Exposed subjects have been found to de-
velop a wide variety of lesions and symptoms
(Table 6). For instance, a typical exposure victim
experiences a number and a variety of clinical
signs and symptoms: early exposure symptoms
may include a burning sensation of the eyes, nose,
and throat followed by headache, dizziness, nau-
sea, and vomiting. Some days later, severe itch-
ing, redness, swelling of the face, more marked
over the eyelids, nose and lips, may develop.
Within the initial weeks after exposure, inflamed
nodules as well as pustules appear on the face,
forearms, shoulders, neck, and trunk, leading then
to comedones and cysts. After a month or two, ac-
neform eruptions emerge and the skin becomes
hyperpigmented. At about the same time, aching
muscles, mainly in the thighs and chest area, be-
come manifest and aggravated on exertion. In-
somnia, extreme irritability, and loss oflibido also
occur during this stage.
Other than the consistently found clinical fea-
ture of acne, other findings in humans may-
include: neuromuscular symptoms (weakness and
pain with nerve conduction abnormalities), por-
phyria cutanea tarda, hepatic dysfunctions, hy-
perlipidemia, cutaneous hyperpigmentation and
hirsutism, chronic eye irritation, emotional dis-
orders, and neuropsychiatric syndromes.
Chloracne, one of the most constant and promi-
nent features of 2,3,7,8-tetra-CDD exposure, has
been described as a refractory acne characterized
by inclusion cysts, comedones and pustules, with
eventual scarring of the skin, more frequently
originating on the face and sometimes spreading
to other parts of the body. Many patients also
have blepharoconjunctivitis and irritation of
other mucous membranes. Sometimes the chlor-
acne is preceded by erythematous and edematous
skin lesions. The latent period between exposure
and the appearance of clear signs of chloracne
ranges from a few weeks to several months (106).
An important and unique episode revolves
around three scientists who were self-exposed to
2,3,7,8-tetra-CDD: one heated trichlorophenol in
an alkaline solution, a second heated potassium
trichlorophenate, and a third worked in the same
laboratory as the second and used a diluted solu-
tion of the synthesized dioxin (107). The first two
scientists developed chloracne eight weeks after
exposure, whereas the third showed no evidence
of the characteristic acneform lesions. Delayed
symptoms, probably due to 2,3,7,8-tetra-CDD, de-
veloped approximately two years later, and the
second two scientists showed personality changes
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Number of
Compound studies Route Species
Dibenzo-p-dioxin 4 Oral (diet) Mouse, rat
Skin Mouse
Mouse (with DMBA)c
2,7-Di-CDD 4 Oral (diet) Mouse, rat
Skin Mouse
Mouse (with DMBA)c
2,3,7-Tri-CDD 3 Oral (gavage) Mouse, rat
Skin Mouse
2,3,7,8-Tetra-CDDd 5 Oral (diet) Rat
Oral (gavage) Mouse
Oral (gavage) Mouse, rat
Skin Mouse
1,2,3,6,7,8-Hexa-CDDd 3 Oral (gavage) Mouse, rat
Skin Mouse
1,2,3,7,8,9-Hexa-CDDd 2 Oral (gavage) Mouse
Skin Mouse (with 1,2,3,6,7,8-hexa-CDD)
1,2,3,4,6,7,8,9-Octa-CDD 3 Oral (diet) Mouse, rat
Skin Mouse
a Data taken from Information Bulletin on the Survey of Chemicals Being Tested for Carcinogenicity, No. 7 (94). Details of
these studies as well as the authors/institutes are available in this source reference document.
b As of October 1979, carcinogenesis bioassay testing within the National Toxicology Program included unsubstituted dibenzo-
p-dioxin (UDD; CAS 262-124; NCI Tech. Rept. No. 122), considered not carcinogenic to Osborne-Mendel rats and B6C3F1 mice
when administered in feed at dose levels of 5 and 10 ppb, and 2,7-dichlorodibenzo-p-dioxin (DCDD; CAS 22857-26-0; NCI Tech.
Rept. No. 123), considered not carcinogenic to Osborne-Mendel rats and female B6C3F1 mice but suggestive of a carcinogenic ef-
fect in male B6C3F1 male mice when fed concentrations of 5 and 10 ppb. Studies are in progress on 1,2,3,6,7,8-hexachlorodibenzo-
p-dioxin (HCDD, CAS 57653-85-7) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD: CAS 1746-01-6) by gavage to Osborne-Mendel
rats and B6C3F1 mice and by skin painting on Swiss mice. Testing on 2,3,7,8-tetrachlorodibenzofuran (TCDF; CAS 51207-31-9) is
to begin in fiscal year 1980. For chemical disposition studies octachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran, and the
stereochemically related 2,4,3',4'-tetrachloroazobenzene are also proposed.
c DMBA = dimethylbenzanthracene.
d The National Toxicology Program has completed and reported the results for the long-termcarcinogenesis bioassay studies on
2,3,7,8-tetrachlorodibenzo-p-dioxin and 1,2,3,6,7,8-/1,2,3,7,8,9-hexachlorodibenzo-p-dioxins, with the following results.
2,3,7,8-tetrachlorodibenzo-p-dioxin-gavage, carcinogenic for Osborne-Mendel rats (increased incidences of follicular-cell thy-
roid tumors in males and of liver tumors in females) and carcinogenic for B6C3F1 mice (liver tumors in both sexes and thyroid
tumors in females); dermal, carcinogenic for female Swiss-Webster mice (fibrosarcoma in the integumentary system) and al-
though not shown carcinogenic for male Swiss-Webster mice, an increase in the same tumor type was observed. Mixture of hex-
achlorodibenzo-p-dioxins-gavage, carcinogenic for female Osborne-Mendel rats (hepatocellular carcinomas or neoplastic nod-
ules), carcinogenic for male and female B6C3F1 mice (hepatocellular carcinomas and adenomas), and not demonstrated as
carcinogenic for male Osborne-Mendel rats; dermal-not considered carcinogenic for male and female Swiss-Webster mice.
(mainly loss of energy and drive); impairment of
vision, taste, and muscular coordination; sleep dis-
turbances; gastrointestinal symptoms; and hir-
sutism. The first of the three experienced none of
these adverse effects. All three exhibited hyper-
cholesterolemia (>300 mg/100 ml).
Human Exposure to PCDDs and PCDFs
Major sources of human exposure to PCDDs
and PCDFs include: exposure in the workplace;
exposure in factories and in the surrounding envi-
ronment from industrial accidents; exposure to
contaminated materials, wastes, or food in the
general environment; and exposure in Vietnam
and other intensive herbicide spraying opera-
tions. (Prior and subsequent to use as a defoliant,
2,4,5-T was used in weed-killing and forest-thin-
ning operations in the United States of America
and elsewhere).
Occupational exposure may occur in manufac-
turing plants producing chlorinated phenols (tri-,
tetra-, and pentachlorophenols), or phenoxy acid
herbicides (2,4-D, 2,4,5-T), or PCBs; in factories
utilizing these chemicals for the production of
other substances (hexachlorophene from 2,4,5-tri-
chlorophenol); in factories manufacturing or re-
pairing transformers and capacitors or having
heat exchange or heat hydraulic systems contain-
ing PCBs; and in the use processes of these chem-
icals under various occupational conditions such
as spraying of herbicides, using chlorinated phe-
nols for a variety of applications (especially wood
preservative), sawing, or otherwise processing
treated wood, and using hexachlorophene in sani-
tary occupations.
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dioxins in humans.
Effects References
Dermatological
Chloracne (25, 28, 95-108)
Porphyria cutanea tarda (27, 104, 105, 109)
Hyperpigmentation and (27, 28,107)
hirsutism
Internal
Liver damagea (27, 95, 98, 101, 102, 104-
106, 110)
Elevated serum hepatic (27, 28, 96, 104-106, 110)
enzyme levels
Disorders of fat metabolism (28, 104, 107)
Disorders of carbohydrate (28, 101, 102, 104, 105)
metabolism
Cardiovascular disorders (101, 102, 104, 105)
Urinary tract disorders (97, 101, 102)
Respiratory disorders (95, 101, 102)
Pancreatic disorders (101, 102)
Neurological
Polyneuropathies (101,102,104, 105)
(peripheral neuritis)
Lower extremity weakness (28, 95, 99, 101, 102, 104,
105, 108)
Sensory impairments (28, 101, 102, 107, 110)
(sight, hearing, smell,
taste)
Psychiatric
Neurasthenic or depressive (28, 95, 99, 101, 102, 104,
syndromes 105, 107)
a Mild fibrosis, fatty changes, hemofuscin deposition and pa-
renchymal-cell degeneration were observed in a few cases.
The burning of materials impregnated with
commercial 2,3,4,6-tetrachlorophenates yielded
150-1000,ug of mixed PCDDs/gchlorophenate. Al-
though only found as a minor constituent, 2,3,7,8-
tetra-CDD has been quantified at levels exceeding
10 ,ug/g chlorophenate (111).
Pyrolysis of a technical grade PCB mixture
yielded many PCDF isomers; the total yield could
be as high as 3-25%. One of the main constituents
is 2,3,7,8-tetra-CDF, the most toxic PCDF-isomer.
Consequently, uncontrolled burning of PCBs can
be an important environmental source of the haz-
ardous PCDFs, and operations such as welding or
soldering electrical equipment containing PCBs,
or using casting waxes in foundries, may possibly
entail a significant exposure (112). A PCB used in
a heat exchange system for two years contained
approximately 1.25 ppm of 2,3,7,8-tetra-CDF and
a total of 15 ppm of PCDFs (113).
Apart from accidents such as the one which oc-
curred in Seveso in 1976, general environmental
exposure may originate from herbicide spraying
and waste disposal.
An outbreak of PCDDs poisoning in humans,
horses, and other animals occurred in Missouri in
1971 (97, 114) following the spraying of contami-
nated oil for dust control in horse arenas.
Another possible source of exposure to PCDDs
and PCDFs pollution are waste oils, and possibly
other waste, when burned both in industrial and
municipal incinerators. Under simulated environ-
mental conditions, the combustion of a standard
2,4,5-T formulation led to formation of small
amounts of PCDDs and PCDFs (115). Buser and
Bosshardt (11) quantified the total amount of
PCDDs and PCDFs in fly ash from an industrial
incinerator heating facility as 0.2 and 0.1 ppm,
and in the fly ash from an industrial heating facil-
ity in Switzerland as 0.6 and 0.3 ppm. More than
30 individual PCDDs can be identified in the fly
ash, but the known highly toxic PCDD isomers
are only minor constituents (12). The number of
PCDF isomers was larger; but, in this case, the
known highly toxic isomers are major constitu-
ents (13).
An additional potential source of human ex-
posure has been revealed: beef fat taken from
cattle grazed on 2,4,5-T-treated rangeland con-
tained 2,3,7,8-tetra-CDD; of the 11/14 positive
samples, the four with the highest levels had 12,
20, 24, and 70 ppt (10). In another study, 3 of 24
samples of beef fat contained 3-4 ppt 2,3,7,8-
tetra-CDD (116). Moreover, in a preliminary re-
port of an ongoing enlarged study of women liv-
ing in areas where 2,4,5-T is used on rangeland, 4/
18 breast milk samples each contained approxi-
mately 1 ppt (10).
Workers in wood processing industries are ex-
posed to wood dust containing preservatives as
well as accompanying impurities and degradation
products. Wood dust from a saw-mill in which a
2,3,4,6-tetrachlorophenol formulation was used as
a fungicide was found to contain 1-10 ppm
PCDFs and <0.5 ppm PCDDs (15).
In 1968, more than 1200 persons in South-west
Japan were intoxicated by consuming a com-
mercial rice oil contaminated with 1000 ppm
PCBs. Nagayama et al. (117) analyzed the rice oil
(Yusho oil) and found 5 ppm PCDFs, the major
constituents of which were tetra- and penta-
CDFs. Buser et al. (113) recently showed that
2,3,7,8-tetra-CDF was the main PCDF in the
Yusho oil (0.45 ppm). The high level of PCDFs
was caused by leakage from heat exchangers con-
taining PCBs contaminated with PCDFs.
Workers manufacturing 2,4,5-trichlorophenol
(TCP) or 2,4,5-T during normal production opera-
tions, and/or following explosions taking place in
these plants, may have been exposed to a variety
of polychlorinated chemicals whose type and
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esses in use and on the phase of the reaction in
which the accident took place. Apparently, for in-
stance, PCDFs are produced in the earlier stages
when mainly tetrachlorobenzene is present and
PCDDs are produced nearer the end of the reac-
tion when primarily trichlorophenol is extant. The
concentration of chlorophenols and chloroben-
zenes, for example, was probably higher in the
1963 episode in The Netherlands, where the acci-
dent took place at the beginning of the reaction,
then in the 1968 episode in the United Kingdom,
or the 1976 accident in Italy, where the explosion
took place at the end.
A thorough description of the reported indus-
trial accidents and other cases of intoxications ob-
served in exposed workers is given in the IARC
Monograph (1). In this present report, only those
episodes specifically discussed at length by the
NIEHS/IARC ad hoc Working Group will be con-
sidered. (A sequential perspective of known acci-
dents is given in Table 7).
In 1949, the first reported cases of industrial
poisoning due to the formation of 2,3,7,8-tetra-
CDD in uncontrolled exothermic reactions oc-
curred during the manufacture of 2,4,5-tri-
chlorophenol at a 2,4,5-T-producing factory in Ni-
tro, West Virginia; 288 persons were affected (99,
118). In November 1953, an accident occurred in
Ludwigshafen, Federal Republic of Germany,
duringthe manufacture of TCP (101,102,119,120);
53 workers were affected by chloracne.
Five cases of chloracne were reported following
an industrial accident in an Italian TCP-produc-
ing factory (121). In 1963, an accident occurred at
the 2,4,5-T-producing factory in The Netherlands;
approximately 50 persons were affected by chlor-
acne (122, 123). In 1966, Dugois et al. (98) ob-
served 21 cases of chloracne after an accident in a
French factory producing TCP in the Grenoble re-
gion. In 1968, an accident occurred at the TCP-
producing factory at Bolsover, Derbyshire,
United Kingdom (103, 106). Within the next 7
months, 79 workers developed chloracne. In 1971,
2,3,7,8-tetra-CDD contaminated waste oil caused
an outbreak of poisoning in humans, horses, and
other animals (97, 124). In July 1976, an accident
at the TCP-producing factory in Meda, Italy (96)
resulted in the contamination of a large, densely
populated area, including the towns of Seveso,
Meda, Cesano Maderno, and Desio.
Key information concerning the effects of hu-
man exposure to herbicides in Vietnam, especially
to the so-called "Agent Orange" (a 50:50 mixture
of the n-butyl esters of 2,4-D and 2,4,5-T, contain-
ing up to 30 mg/kg or more 2,3,7,8-tetra-CDD),
may be found in the literature (1, 110, 125-127).*
Exposure Episodes Considered in
Detail by the NIEHS/IARC adhoc
Working Group
The text below is a condensed version of the
discussions which took place during the two-day
NIEHS/IARC ad hoc Working Group Meeting.
Phenoxy Acids Exposure
Cohort studies on herbicide sprayers have been
conducted or are being planned in Scandinavian
countries. The more advanced of these concerns
Swedish railroad workers with exposure to a vari-
ety of herbicides. These people exhibited a signif-
icantly increased tumor incidence (apparently
dose-dependent) and tumor mortality (129). The
excess of tumors was found particularly among
workers with exposure to amitrole (amino-
triazole), whereas those exposed to phenoxy acids
(2,4-D and 2,4,5-T) showed only a slightly in-
creased excess of cancers. The study was small-
sized, comprising 2978 person-years at observa-
tion in the total cohort and with 18 deaths versus
20.54 expected. The original conclusion from this
study was that amitrole exposure may have
caused an excess of tumors, whereas there was
probably no pertinent increase in tumor incidence
associated with exposure to phenoxy acids. The
study has been recently reanalysed using a case-
control approach, and through stratification on
amitrole when considering the effect from phe-
noxy acids, and vice versa. The results show a pos-
sible and previously masked tumor-inducing ef-
fect also from phenoxy acids.
Another retrospective cohort mortality study,
conducted in Finland on workers of five com-
panies involved in spraying 2,4-D and 2,4,5-T on
brushwood, did not show any increase in mortal-
ity. During 1955-1971, in the younger group of
workers (under 45 years of age), however, four
cancer deaths were observed versus less than two
expected (no statistically significant difference).
A prospective follow-up study for the period 1972-
1976 revealed fewer cancer-related deaths than
expected in all age groups. Clinical and anamnes-
* More than 2,000,000 gallons of Agent Orange remaining
from military defoliant operations were destroyed by in-
cineration on board ship in the Pacific Ocean, 120 miles from
Johnston Island. Temperatures not lower than 1250°C were
used. The steel containers were melted (128).
Environmental Health Perspectives 230tic investigations were also performed showing a
picture of acute complaints during and following
the spraying operations: headache, transient diz-
ziness, fatigue, abdominal complaints, skin and
mucous irritations, and a few cases of persistent
papulae.
Interestingly, some samples of 2,4,5-T used in
Finland for spraying operations contained from
0.04 to 0.07 ppm 2,3,7,8-tetra-CDD. This may im-
ply that the 2,4,5-T produced before 1965 con-
tained lower levels of 2,3,7,8-tetra-CDD impur-
ities than has been observed subsequently from
2,4,5-T used elsewhere. However, the analytical
methods used in the determination of 2,3,7,8-
tetra-CDD in the Finnish samples were anti-
quated in view of the rapid advancements made
in analytical methodology and thus a con-
firmatory analysis of the samples using modern
techniques was made by Rappe et al. (130). Five
samples of 2,4,5-T ester dating from 1962 to 1967
were analysed for PCDDs and PCDFs; levels of
0.1-0.95 ppm 2,3,7,8-tetra-CDD and 0.1-0.15 ppm
tetra-CDF were found.
A second feasibility study was designed and
conducted in Finland to determine whether one
could obtain anamnestic, clinical, hematological,
and immunological information on Finnish
railway and forestry workers who had been ex-
posed for several years to herbicides containing
2,3,7,8-tetra-CDD. The exposed group consisted of
30 men who were control-matched to persons of
the same age coming from the same district with
similar job backgrounds and living conditions. Of
the tests made, including liver and immuno-
function studies, no differences were observed be-
tween the exposed and control groups. Although
the population study is too small to permit any
general conclusions as to the potential adverse
health effects from long-term exposure to phe-
noxy acids, the investigation shows that follow-up
is possible on the health status of persons exposed
for several years to 2,3,7,8-tetra-CDD-containing
phenoxy acids, and then to compare the exposed
group results to carefully matched controls. The
study is in progress.
Hexachlorophene Exposure
An excess of malformations, some severe, has
been reported among children whose mothers
were employed as nurses in a hospital. The
mothers were exposed to hexachlorophene soap
during early pregnancy, and the hypothesis of a
causal relation between such an exposure and the
occurrence of the malformations has been ad-
vanced (131); five severe and six slight malforma-
tions were observed in 65 children in the exposed
group, whereas only one slight malformation was
observed in the 68 children of the unexposed
group. This report has been followed by another
study (to be published) of a similar group of chil-
dren of exposed mothers in comparison to chil-
dren of unexposed mothers. Again a high fre-
quency of malformations among the offspring of
exposed mothers was reported (132). From these
studies, however, it is not clear if exposure to
other hazardous chemicals could be excluded. A
retrospective-prospective study is being initiated
among long-term workers of an United States'
factory which used Seveso-produced 2,4,5-tri-
chlorophenol in the manufacture of hexachloro-
phene. However, in the case of hexachlorophene,
polychlorinated xanthenes have been also identi-
fied as contaminants at a higher level than 2,3,7,8-
tetra-CDD (133).
Phenoxyacids and Chlorophenols
Exposure in Forestry and in Wood
Industry Workers
At the Regional Hospital in Umea (Northern
Sweden), Hardell (134) observed that several pa-
tients suffering from mesenchymal tumors re-
ported occupational or other exposures to phen-
oxyacids. More specifically, 87 mesenchymal
tumors were diagnosed during the years 1970
through 1976. Of these cases, 55 were men (more
than expected) and 43 of these 55 men were
known by profession: 19 were either forestry
workers, farmers and forestry workers, or work-
ers in sawmills and papermills where exposure to
chlorophenols is common. Based on the official sta-
tistics of Sweden, one can calculate approximat-
ively the expected fraction of tumors within these
trades, resulting in an expectancy of approxi-
mately 11 cases versus the 19 observed.
The Mount Sinai School of Medicine in New
York is currently planning a field survey on long-
term health effects on wood-preservative workers
in Arkansas and Oklahoma in the United States
of America.
Exposure to 2,3,7,8-Tetra-CDD during
Production of2,4,5-T or
Polychlorinated Phenols and Following
Industrial Accidents
The following cases, as well as others not con-
sidered at the meeting, have been described in
IARC Monographs Volume 15 (1), and only some
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given here. The ongoing epidemiological studies
on these cohorts are summarized in Table 7.
As each individual cohort has a relatively small
number of person-years, a study has been pro-
posed in which all the cohorts would be pooled and
the mortality compared to that expected from the
national statistics.
The first reported cases of industrial poisoning
due to the formation of 2,3,7,8-tetra-CDD in un-
controlled exothermic reactions occurring during
the manufacture of TCP were seen in 1949 at a
2,4,5-T-producing factory in Nitro, West Virginia,
USA; 228 persons were affected. These individuals
were studied by Suskind and Ashe (135) and fol-
lowed up for a period of four years. Symptoms in-
cluded chloracne, nausea, vomiting, headaches, se-
vere muscular aches and pain, fatigue, emotional
instability, and intolerance to cold. Laboratory
findings showed raised total lipids and raised pro-
thrombin time. Among those affected were not
only workmen, but also laboratory personnel,
medical personnel, and even the Safety Director
who visited the areas of exposure. Several wives
who had never visited the plant also developed
acne, usually at the same time as their employee
husbands.
It is important to note that information on the
toxicity as well as on the stability (long per-
sistence and slow degradability) of 2,3,7,8-tetra-
CDD was not available at the time the first re-
ports of acute toxicity were observed, and no
measures were taken to decontaminate the facto-
ries and control the residue levels of 2,3,7,8-tetra-
CDD. In fact, the presence of 2,3,7,8-tetra-CDD or
other PCDDs and PCDFs was not even suspected.
Workers, therefore, were probably exposed for a
considerable time to 2,3,7,8-tetra-CDD following
the first observations of acute toxic effects.
In November 1953, an accident occurred at a
TCP factory in Ludwigshafen, Federal Republic
of Germany; 75 workers were exposed to the reac-
tion products during the accident and the sub-
sequent cleaning work; most were affected by
chloracne, 42 severely: 21 of the 42 suffered con-
sequent damage to internal organs or distur-
bances of the nervous system. The most relevant
features were polyneuritis, sensorial impair-
ments, and liver damage. The son of one of the
workers developed chloracne following contact
with his father's work clothes. An additional case
of poisoning occurred 5 years later in a worker
who was involved in repair work (welding one of
the auto-claves) at the contaminated site; sub-
sequently this worker died with necrotic pan-
creatitis.
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All the 75 workers could be traced in a cohort
study 25 years later; mortality was compared both
with the regional and national mortality and with
a control group of workers from the same factory.
In the exposed group, 17 deaths were observed
(11 to 25 expected depending on the control popu-
lation); six from cancer (four or less expected),
five from cardiovascular diseases (as expected),
two from suicides (0.2-0.6 expected), one from
liver cirrhosis, one from a urogenital tract dis-
ease, and two from traffic accidents.
Of the six cancer deaths, three were from stom-
ach cancer and occurred in the age group of 60-69,
which is significantly more than expected. This
effect was more pronounced when a minimum ob-
servation period of 10 years was considered, and
more so for stomach cancer after a 20-year obser-
vation period. (Use of a long observation period
permits a better estimation of the relation be-
tween exposure and disease when long "latency"
periods are involved, as for cancers).
A similar accident occurred at the 2,4,5-T-pro-
ducing factory in The Netherlands in 1963; 106
men are likely to have been exposed to 2,3,7,8-
tetra-CDD (and possibly PCDFs) as they were in
the building where the accident occurred during
the subsequent period, March-July 1963. These
workers may be divided into three groups: (A)
factory employees (exposed during all phases of
the cleaning and reconstruction activities), 44
men; (B) clean-up crew (nonfactory personnel,
exposed during the months May-July), 18 men;
and (C) plumbing, painting, and insulating per-
sonnel (nonfactory workers, exposed during the
months May-July), 44 men.
During the explosion in Amsterdam, two oper-
ators were present in the building. With the ex-
ception of these men, who were probably exposed
primarily by the inhalation route, all other work-
ers used safety masks and were probably exposed
by dermal contact. Chloracne was the most com-
mon and prominent lesion observed following
2,3,7,8-tetra-CDD exposure (26/44 examined in
group A, 10/16 in group B, and 8/16 in the group
C). Liver function tests (thymol turbidity and
serum glutamic pyruvic transaminase and serum
glutamic oxaloacetic transaminase) did not in-
dicate liver damage. A few men complained of fa-
tigue. The latent period between exposure and
the appearance of chloracne, characterized by
comedones, pustules, and cysts on the face and
sometimes on other parts of the body, was ap-
proximately 4-6 weeks. Sometimes, erythematous
and edematous skin lesions, possibly due to phe-
nolic compounds, were noted one day after ex-
posure. No skin lesions (chloracne) were reported
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3/44 workers died, one of pancreas carcinoma in
1964, one of myocardial infarction at the age of
69, and one of a traffic accident. Of the 17/18
traced individuals in the B group, four have died
(three from sudden death, probably of myocardial
infarction, at ages, 41, 53, and 65, and one of ill-
defined pulmonary or cardiac cause at age 44).
Only 32/44 of the C group were traced, and one of
them died of sudden death, probably myocardial
infarction, at age 50.
Jirasek et al. (104, 105, 109) studied 55 subjects
from a cohort of 78 workers from a factory in
Czechoslovakia producing 2,4,5-T and pen-
tachlorophenol, who were affected by chloracne.
The workers were probably exposed during the
years 1965-1968 to unknown levels of 2,3,7,8-tetra-
CDD. A significant symptom was the disturbance
in porphyrins metabolism with signs of porphyria
cutanea tarda. Many workers also suffered severe
hepatic and neurological damage and had raised
blood levels of cholesterol and total lipids. In the
first years of follow-up, five deaths were observed,
two from bronchogenic carcinoma at age 47 and
59 (only 0.12 lung cancer deaths were expected
from national mortality statistics), one from
atypical atherosclerosis at age 57, and one from
the acute occupational intoxication. One further
death, probably from liver cirrhosis, has recently
been observed and 50 workers are still being fol-
lowed. Many workers continue to show lipemia
and hypercholesterolemia and have developed
prediabetic changes and hypertension. The work-
ers lost to follow-up are mostly foreigners who re-
turned to their country of origin.
In July 1976, an accident in a TCP-producing
factory in Meda, Italy resulted in the con-
tamination of the towns of Seveso, Meda, Cesano
Maderno, Desio, Nova Milanese, and possibly oth-
ers of a large, densely populated area called the
Brianza di Seveso with a total population of about
220,000 inhabitants. A retrospective health survey
conducted on the workers of the ICMESA factory
revealed that two workers among those directly
involved in the production of 2,4,5-trichlorophenol
suffered from skin lesions previous to July 1976.
These facts may be indicative of a previous
2,3,7,8-tetra-CDD exposure.
A large and intensive follow-up program is in
progress in the Seveso area; data were presented
about the first dermatological, neurological, clini-
cal, and laboratory findings, as well as about fetal
damage. Dermatological examinations, including
the screening of 32,000 children, resulted in the
finding of hundreds of children with skin lesions,
135 of which were eventually identified as chlor-
acne; 59 cases were from the more contaminated
area (Zone A). However, precise description of
diagnostic criteria and accurate anamnestic infor-
mation, including, amongothers, data on places of
residence, were not included. This information is
needed before evaluating the meaning of the
chloracne incidence data by territorial areas and
efforts should be made obtain it. Chloracne cases
were not systematically searched for in adults.
Neurological examinations showed both signs of
subclinical neurological damage and cases of clini-
cally detectable polyneuropathy in adults (34/338
persons from zone A and 8/185 from the sur-
rounding areas).
In about 30% of 1654 adults from both A zone
and nearby zones, hepatomegaly was reported to
be present on clinical investigation. No informa-
tion, however, is given on the criteria by which
the hepatomegaly was evaluated. The same per-
centage of abnormalities was observed in one or
more liver tests (mainly glutamyl transferase
and serum glutamic pyruvic transaminase and
serum glutamic oxaloacetic transaminase). Ex-
tensive monitoring of various hematological pa-
rameters from 25,000 persons is now in progress
and the data are expected to become available
during 1978. Results of this investigation should
allow a better understanding as to whether or not
these alterations are caused by exposure to
2,3,7,8-tetra-CDD and PCDDs.
So far, immunological investigations, cyto-
genetic research, and embryomorphology analy-
ses on cases of therapeutical abortions have not
given abnormal results. However, the study of the
frequency of congenital malformations and spon-
taneous abortions seems to be very difficult to ac-
complish. The importance of a systematic study
on this subject has been stressed by the Working
Group, because the questions on the teratogeni-
city of 2,3,7,8-tetra-CDD in humans cannot be
solved by any other study.
A preliminary mortality study has been pos-
sible in 2 of the 11 towns of the Seveso area. The
1975-1977 mortality rates from liver cirrhosis and
leukemia in these two limited zones of the Seveso
area were compared to that of a nearby area
(province of Varese). Within an overall mortality
which did not appear different, an increase of
deaths from liver cirrhosis and from leukemia
was noted. The validity and significance of these
observations should be carefully evaluated.
Recommendations
A chemical analytical program should be en-
couraged to identify and standardize analytical
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November 1980 235methods used, to catalogue products contami-
nated with PCDDs and PCDFs, and to establish a
register of known PCDD and PCDF standard
samples.
The Working Group unanimously recommended
that a system be developed for an international
exchange of information and research coordina-
tion on the health effects of chlorinated dibenzo-p-
dioxins/chlorinated dibenzofurans. Further, and
in particular, the following three areas were in-
dicated as deserving special attention:
1. Development of sensitive and reliable mea-
surements of body burden; improved, more sensi-
tive, and less expensive analytical technology
should be generated. Standardized sampling (air,
water, soil, tissues and body fluids, environmen-
tal), preparation, clean-up, and analysis should be
promoted;
2. Development of common protocols for clini-
cal examinations (including reproductive experi-
ence) and, in particular, design of a protocol for
basic core information;
3. Development of an international registry of
exposed persons to serve as a basis for long-term
follow-up: this was considered especially impor-
tant because the relatively small size of popu-
lations involved in individual exposure episodes
are an obstacle to risk assessment and thus pool-
ing of data is almost a necessity.
The Working Group recommended that IARC
explore the technical and financial feasibility, pos-
sibly in cooperation with other national and/or in-
ternational organizations, of setting-up such a
permanent mechanism which could include as a
minimum starting program: (a) a periodical, per-
haps biennial, meeting to up-date the progress of
ongoing studies, and to identify needed develop-
ments; (b) an exchange of relevant information
accruing during the interval between meetings;
and (c) a register of chloracne cases, containing
simple, essential information in a standardized
form. This PCDDs/PCDFs exposure-related sign
may help to better define an exposed cohort popu-
lation suitable for long-term follow-up.
This report represents the views and opinions of the U.S.
NIEHS/IARC (National Institute of Environmental Health
Sciences/International Agency for Research on Cancer ad hoc
Working Group which met January 10-11, 1978 in Lyon
France to review the history of human exposure to these
chemicals, to collate current information, and toplan and fore-
cast needed new directions. The meeting was funded jointly
by NIEHS and IARC.
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